Title: Copper Oxide Nanoparticle-Induced Acute Inflammatory Response and Injury in Murine Lung Is Ameliorated by Synthetic Secoisolariciresinol Diglucoside (LGM2605).
Authors: Pietrofesa, Ralph A; Park, Kyewon; Mishra, Om P; Johnson-McDaniel, Darrah; Myerson, Jacob W; Shuvaev, Vladimir V; Arguiri, Evguenia; Chatterjee, Shampa; Moorthy, Ganesh S; Zuppa, Athena; Hwang, Wei-Ting; Christofidou-Solomidou, Melpo
Published In Int J Mol Sci, (2021 Aug 31)
Abstract: Metal-oxide nanoparticles (MO-NPs), such as the highly bioreactive copper-based nanoparticles (CuO-NPs), are widely used in manufacturing of hundreds of commercial products. Epidemiological studies correlated levels of nanoparticles in ambient air with a significant increase in lung disease. CuO-NPs, specifically, were among the most potent in a set of metal-oxides and carbons studied in parallel regarding DNA damage and cytotoxicity. Despite advances in nanotoxicology research and the characterization of their toxicity, the exact mechanism(s) of toxicity are yet to be defined. We identified chlorination toxicity as a damaging consequence of inflammation and myeloperoxidase (MPO) activation, resulting in macromolecular damage and cell damage/death. We hypothesized that the inhalation of CuO-NPs elicits an inflammatory response resulting in chlorination damage in cells and lung tissues. We further tested the protective action of LGM2605, a synthetic small molecule with known scavenging properties for reactive oxygen species (ROS), but most importantly, for active chlorine species (ACS) and an inhibitor of MPO. CuO-NPs (15 µg/bolus) were instilled intranasally in mice and the kinetics of the inflammatory response in lungs was evaluated 1, 3, and 7 days later. Evaluation of the protective action of LGM2605 was performed at 24 h post-challenge, which was selected as the peak acute inflammatory response to CuO-NP. LGM2605 was given daily via gavage to mice starting 2 days prior to the time of the insult (100 mg/kg). CuO-NPs induced a significant inflammatory influx, inflammasome-relevant cytokine release, and chlorination damage in mouse lungs, which was mitigated by the action of LGM2605. Preventive action of LGM2605 ameliorated the adverse effects of CuO-NP in lung.
PubMed ID: 34502389
MeSH Terms: Animals; Bronchoalveolar Lavage Fluid/cytology; Butylene Glycols/metabolism; Butylene Glycols/pharmacology*; Chlorine/metabolism; Copper/metabolism; Copper/toxicity; DNA Damage/drug effects; Female; Glucosides/metabolism; Glucosides/pharmacology*; Inflammasomes/drug effects; Inflammation/drug therapy*; Lung/drug effects; Metal Nanoparticles/adverse effects; Mice; Mice, Inbred C57BL; Oxidative Stress; Oxides/pharmacology; Peroxidase/pharmacology; Reactive Oxygen Species/pharmacology